XyloCor Therapeutics logo

XyloCor Therapeutics Funding & Investors

Malvern, PA

XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.

xylocor.com

Total Amount Raised: $107,100,000

XyloCor Therapeutics Funding Rounds

  • Series B

    $67,500,000

    Series B Investors

    Jeito Capital
    Lumira Ventures
    LSP
    Fountain Healthcare Partners

  • Series A

    $22,600,000

    Series A Investors

    Fountain Healthcare Partners
    Lumira Ventures
    Sofinnova Ventures
    LSP
    Longwood Fund

  • Series A

    $17,000,000

    Series A Investors

    LSP
    Sofinnova Ventures
Funding info provided by Diffbot.